Sivapalaratnam Suthesh, Westbury Sarah K, Stephens Jonathan C, Greene Daniel, Downes Kate, Kelly Anne M, Lentaigne Claire, Astle William J, Huizinga Eric G, Nurden Paquita, Papadia Sofia, Peerlinck Kathelijne, Penkett Christopher J, Perry David J, Roughley Catherine, Simeoni Ilenia, Stirrups Kathleen, Hart Daniel P, Tait R Campbell, Mumford Andrew D, Laffan Michael A, Freson Kathleen, Ouwehand Willem H, Kunishima Shinji, Turro Ernest
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.
Blood. 2017 Jan 26;129(4):520-524. doi: 10.1182/blood-2016-08-732248. Epub 2016 Nov 14.
The von Willebrand receptor complex, which is composed of the glycoproteins Ibα, Ibβ, GPV, and GPIX, plays an essential role in the earliest steps in hemostasis. During the last 4 decades, it has become apparent that loss of function of any 1 of 3 of the genes encoding these glycoproteins (namely, GP1BA, GP1BB, and GP9) leads to autosomal recessive macrothrombocytopenia complicated by bleeding. A small number of variants in GP1BA have been reported to cause a milder and dominant form of macrothrombocytopenia, but only 2 tentative reports exist of such a variant in GP1BB By analyzing data from a collection of more than 1000 genome-sequenced patients with a rare bleeding and/or platelet disorder, we have identified a significant association between rare monoallelic variants in GP1BB and macrothrombocytopenia. To strengthen our findings, we sought further cases in 2 additional collections in the United Kingdom and Japan. Across 18 families exhibiting phenotypes consistent with autosomal dominant inheritance of macrothrombocytopenia, we report on 27 affected cases carrying 1 of 9 rare variants in GP1BB.
血管性血友病因子受体复合物由糖蛋白Ibα、Ibβ、GPV和GPIX组成,在止血的最初步骤中起关键作用。在过去40年里,编码这些糖蛋白的3个基因(即GP1BA、GP1BB和GP9)中任何一个功能丧失都会导致常染色体隐性大血小板减少症并伴有出血,这一点已变得很明显。据报道,GP1BA中的少数变异会导致一种较温和的显性大血小板减少症,但关于GP1BB中此类变异仅有2篇初步报告。通过分析1000多名患有罕见出血和/或血小板疾病的基因组测序患者的数据,我们发现GP1BB中的罕见单等位基因变异与大血小板减少症之间存在显著关联。为了强化我们的发现,我们在英国和日本的另外2组样本中寻找更多病例。在18个表现出与大血小板减少症常染色体显性遗传一致的表型的家族中,我们报告了27例受影响病例,这些病例携带GP1BB中9种罕见变异中的1种。